“Molecular Docking study, and In vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone against breast cancer cell line (MCF-7)”, AJPS, vol. 22, no. 3, pp. 24–34, Oct. 2022, doi: 10.32947/ajps.v22i3.886.